Table 2 Patient Demographic Data
From: Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Worse Vision PPV (N = 8) | Injection (N = 5) | Better Vision PPV (N = 10) | Total (N = 23) | P | |
|---|---|---|---|---|---|
Sex, N (%) | 0.145 | ||||
Female | 6 (75.0) | 4 (80.0) | 3 (30.0) | 13 (56.5) | |
Male | 2 (25.0) | 1 (20.0) | 7 (70.0) | 10 (43.5) | |
Age (years) | 0.238† | ||||
Mean ± SD | 55.1 ± 20.1 | 54.2 ± 14.5 | 66.4 ± 12.0 | 59.8 ± 16.1 | |
Median (range) | 60.5 (23.0 to 80.0) | 60.0 (35.0 to 69.0) | 70.0 (45.0 to 81.0) | 67.0 (23.0 to 81.0) | |
Eye, N (%) | 0.856 | ||||
OD | 4 (50.0) | 3 (60.0) | 7 (70.0) | 14 (60.9) | |
OS | 4 (50.0) | 2 (40.0) | 3 (30.0) | 9 (39.1) | |
Indication IVI. N (%) | 0.685 | ||||
AMD | 3 (37.5) | 1 (20.0) | 5 (50.0) | 9 (39.1) | |
Angioid Streaks | 0 (0.0) | 1 (20.0) | 0 (0.0) | 1 (4.3) | |
CRVO | 1 (12.5) | 1 (20.0) | 2 (20.0) | 4 (17.4) | |
CSR | 1 (12.5) | 0 (0.0) | 0 (0.0) | 1 (4.3) | |
DME | 1 (12.5) | 2 (40.0) | 3 (30.0) | 6 (26.1) | |
PDR | 1 (12.5) | 0 (0.0) | 0 (0.0) | 1 (4.3) | |
Preoperative | 1 (12.5) | 0 (0.0) | 0 (0.0) | 1 (4.3) | |
Pathogen N (%) | 0.729 | ||||
Brevibacillus spp. | 1 (12.5) | 0 (0.0) | 0 (0.0) | 1 (4.3) | |
Staphylococcus spp. | 6 (75.0) | 5 (100.0) | 8 (80.0) | 19 (82.6) | |
Streptococcus spp. | 1 (12.5) | 0 (0.0) | 2 (20.0) | 3 (13.0) |